調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Microtome Market by Product (Instruments, (Rotary, Cryostat), Accessories), Application (Disease Diagnosis, Medical Research), Technology (Manual, Semi-automated, Fully Automated), End User (Hospital, Clinical Laboratories) - Global Forecast to 2024

ミクロトームの世界市場予測（～2024年）

◆タイトル：Microtome Market by Product (Instruments, (Rotary, Cryostat), Accessories), Application (Disease Diagnosis, Medical Research), Technology (Manual, Semi-automated, Fully Automated), End User (Hospital, Clinical Laboratories) - Global Forecast to 2024
◆商品コード：MD 7308
◆調査・発行会社：MarketsandMarkets
◆発行日：2019年8月30日
◆ページ数：124
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧）	USD4,950 ⇒換算￥539,550	見積依頼/購入/質問フォーム
Multi User (Five User)	USD6,650 ⇒換算￥724,850	見積依頼/購入/質問フォーム
Corporate License (全社内共有可)	USD8,150 ⇒換算￥888,350	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、ミクロトームの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別（機器（ロータリー、クライオスタット）、アクセサリ）分析、用途別（疾患診断、医学研究）分析、技術別（手動、半自動、全自動）分析、エンドユーザー別（病院、臨床検査室）分析、ミクロトームの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。MarketsandMarkets社は、ミクロトームの世界市場規模が2019年129百万ドルから2024年177百万ドルまで年平均6.5%成長すると予測しています。

“High prevalence of cancer, growing demand for digital pathology, and increasing healthcare expenditure are expected to drive the overall growth of the microtomes market”The microtomes market is expected to reach USD 177 million by 2024 from USD 129 million in 2019, at a CAGR of 6.5% during the forecast period. This market is experiencing significant growth due to the growing demand for digital pathology, high prevalence of cancer, and increasing healthcare expenditure. Also, the increasing focus on personalized medicine and the emerging economies are offering growth opportunities for players in the microtomes market. However, a lack of skilled professionals to operate microtomes is expected to restrain the growth of this market during the forecast period.

“Disease diagnosis is expected to dominate the market during the forecast period.”
Based on application, the microtomes market is segmented into disease diagnosis and medical research. Disease diagnosis accounted for the larger market share in 2018, as compared to other segments. Growth in the geriatric population and the increasing incidences of cancer and other chronic diseases are the factors contributing to the larger market share.

“Hospital laboratories to witness the highest growth in microtomes market, by the end-user, in 2018”
Based on end-user, the microtomes market is segmented into clinical laboratories, hospital laboratories, and other end users. The hospital laboratories segment accounted for the largest market share in 2018 as well as the highest CAGR during the forecast period. The large share and the highest growth of the hospital laboratories segment are attributed to the increasing number of patient visits to hospitals, rising number of in-house clinical diagnostic procedures performed in hospitals, growing awareness regarding early diagnosis, and the availability of reimbursements in developed markets for clinical tests performed in hospitals.

“North America to dominate the market during the forecast period”
Geographically, the microtomes market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2018, North America accounted for the largest share of the microtomes market. Growing opportunities for advanced cancer diagnostic testing and screening, the easy accessibility to advanced technologies, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region are the major factors driving the growth of the microtomes market in North America.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Tier 1: 36%, Tier 2: 45%, and Tier 3: 19%
• By Designation – C-level: 33%, D-level: 40%, and Others: 27%
• By Region – North America: 36%, Europe: 28%, Asia Pacific: 19%, Rest of the World: 17%

List of Companies Profiled in the Report
• Thermo Fisher Scientific (US)
• Danaher Corporation (US)
• Diapath S.P.A.
• Sakura Finetek (Japan)
• SLEE Medical GmbH (Germany)
• MEDITE GmbH (Germany)
• Histo-Line Laboratories (Italy)
• Amos Scientific (Australia)
• RMC Boeckeler, Diapath S.p.A. (Italy)
• Jinhua YIDI Medical Appliance (China)

Research Coverage:
This report provides a detailed picture of the global microtomes market. It aims at estimating the size and future growth potential of the market across different segments, such as product, technology, application, end-user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall microtomes market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, and opportunities.

【レポートの目次】

1 Introduction (Page No. – 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitation
1.6 Stakeholders
2 Research Methodology (Page No. – 18)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Source
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3 Executive Summary (Page No. – 24)
4 Premium Insights (Page No. – 28)
4.1 Microtomes: Market Overview
4.2 Asia Pacific: Microtomes Market Share, By End User and Country (2019)
4.3 Microtomes Market, By Technology (USD Million)
4.4 Microtomes Market, By Application, 2019 vs. 2024 (USD Million)
4.5 Microtomes Market, By Product, 2019 vs. 2024 (USD Million)
4.6 Geographical Snapshot of the Microtomes Market
5 Market Overview (Page No. – 32)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 High Prevalence of Cancer
5.2.1.2 Growing Demand for Digital Pathology
5.2.1.3 Increasing Healthcare Expenditure
5.2.2 Market Restraints
5.2.2.1 Lack of Skilled Professionals
5.2.3 Market Opportunities
5.2.3.1 Growing Focus on Personalized Medicine
5.2.3.2 Emerging Economies
6 Microtomes Market, By Product (Page No. – 37)
6.1 Introduction
6.2 Microtome Instruments
6.2.1 Rotary Microtomes
6.2.1.1 Rotary Microtomes are the Most Common Types of Microtomes Used in Histology Laboratories
6.2.2 Cryostat Microtomes
6.2.2.1 Cryostat Microtomes Provide Immediate Results By Quickly, Reliably, and Safely Cutting Accurate Frozen Sections
6.2.3 Vibrating Microtomes
6.2.3.1 Vibrating Microtomes are Designed to Cut Fresh Tissue Specimens
6.2.4 Other Microtomes
6.3 Microtome Accessories
6.3.1 The Adoption of Disposable Blades has Increased as they Help in Producing High-Quality Sections
7 Microtomes Market, By Application (Page No. – 45)
7.1 Introduction
7.2 Disease Diagnosis
7.2.1 High Prevalence of Cancer to Drive Market Growth
7.3 Medical Research
7.3.1 Increasing Research Activities to Drive the Adoption of Microtomes
8 Microtomes Market, By Technology (Page No. – 49)
8.1 Introduction
8.2 Manual Microtomes
8.2.1 Lower Cost and User Comfort Associated With these Microtomes are Driving their Adoption
8.3 Semi-Automated Microtomes
8.3.1 Semi-Automated Microtomes to Register the Highest Growth Rate During the Forecast Period
8.4 Fully Automated Microtomes
8.4.1 Lack of Clinical Laboratory Technicians and the High Prevalence of Cancer Have Resulted in the Increased Adoption of Fully Automated Microtomes
9 Microtomes Market, By End User (Page No. – 54)
9.1 Introduction
9.2 Hospital Laboratories
9.2.1 Hospital Laboratories Accounted for the Largest Share of the Market, By End User
9.3 Clinical Laboratories
9.3.1 Presence of Robust Infrastructure to Perform Tests in High Volumes is Estimated to Drive Market Growth
9.4 Other End Users
10 Microtomes Market, By Region (Page No. – 59)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 High Burden of Cancer and Numerous Conferences on Anatomic Pathology to Drive Market Growth
10.2.2 Canada
10.2.2.1 Availability of Research Funding & Rising Incidence of Cancer to Drive Market Growth
10.3 Europe
10.3.1 Germany
10.3.1.1 Increasing Prevalence of Chronic Diseases and Large-Scale Outsourcing of Clinical Diagnostic Tests By Hospitals to Commercial Service Providers to Support Market Growth
10.3.2 UK
10.3.2.1 Government Initiatives to Drive Market Growth in the UK
10.3.3 France
10.3.3.1 High Prevalence of Cancer to Support Market Growth in France
10.3.4 Italy
10.3.4.1 High Prevalence of Cancer and Increasing Per Capita Healthcare Spending to Support Market Growth in Italy
10.3.5 Spain
10.3.5.1 High Incidence of Chronic Diseases to Drive Market Growth in Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.1.1 Presence of A Well-Developed Healthcare System to Support Market Growth in Japan
10.4.2 China
10.4.2.1 Rising Healthcare Expenditure to Drive the Market Growth
10.4.3 India
10.4.3.1 Growing Healthcare Sector in the Country to Drive Market Growth
10.4.4 Rest of Asia Pacific
10.5 Rest of the World
11 Competitive Landscape (Page No. – 96)
11.1 Overview
11.2 Market Share Analysis, 2018
11.3 Competitive Scenario
11.3.1 Partnerships, Agreements, and Collaborations (2016–2019)
11.3.2 Product Launches (2016–2019)
11.3.3 Acquisitions (2016–2019)
11.4 Competitive Leadership Mapping (Overall Market)
11.4.1 Vendor Inclusion Criteria
11.4.2 Vanguards
11.4.3 Innovators
11.4.4 Dynamic Players
11.4.5 Emerging Players
12 Company Profiles (Page No. – 101)
(Business Overview, Products Offered, Recent Developments, MnM View)*
12.1 Amos Scientific Pty Ltd
12.2 Danaher
12.3 Diapath S.p.A.
12.4 Histo-Line Laboratories
12.5 Jinhua YIDI Medical Appliance Co.,Ltd
12.6 MEDITE GmbH
12.7 RMC Boeckeler
12.8 Sakura Finetek
12.9 SLEE Medical GmbH
12.10 Thermo Fisher Scientific
*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.
13 Appendix (Page No. – 116)
13.1 Insights From Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Available Customization
13.5 Related Reports
13.6 Author Details

List of Tables (97 Tables)
Table 1 Global Cancer Incidence, 2018 vs. 2025
Table 2 Healthcare Spending (% of GDP), By Country, 2006 vs. 2016
Table 3 Growth in the Number of Personalized Medicines, 2008–2016
Table 4 Microtomes Market, By Product, 2017–2024 (USD Million)
Table 5 Microtome Instruments Market, By Region, 2017–2024 (USD Million)
Table 6 Microtome Instruments Market, By Type, 2017–2024 (USD Million)
Table 7 Rotary Microtomes Market, By Region, 2017–2024 (USD Million)
Table 8 Cryostat Microtomes Market, By Region, 2017–2024 (USD Million)
Table 9 Vibrating Microtomes Market, By Region, 2017–2024 (USD Million)
Table 10 Other Microtomes Market, By Region, 2017–2024 (USD Million)
Table 11 Microtome Accessories Market, By Region, 2017–2024 (USD Million)
Table 12 Microtomes Market, By Application, 2017–2024 (USD Million)
Table 13 Microtomes Market for Disease Diagnosis, By Region, 2017–2024 (USD Million)
Table 14 Microtomes Market for Medical Research, By Region, 2017–2024 (USD Million)
Table 15 Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 16 Manual Microtomes Market, By Region, 2017–2024 (USD Million)
Table 17 Semi-Automated Microtomes Market, By Region, 2017–2024 (USD Million)
Table 18 Fully Automated Microtomes Market, By Region, 2017–2024 (USD Million)
Table 19 Microtomes Market, By End User, 2017–2024 (USD Million)
Table 20 Microtomes Market for Hospital Laboratories, By Region, 2017–2024 (USD Million)
Table 21 Microtomes Market for Clinical Laboratories, By Region, 2017–2024 (USD Million)
Table 22 Microtomes Market for Other End Users, By Region, 2017–2024 (USD Million)
Table 23 Microtomes Market, By Region, 2017–2024 (USD Million)
Table 24 North America: Microtomes Market, By Country, 2017–2024 (USD Million)
Table 25 North America: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 26 North America: Microtome Instruments Market, By Type, 2017–2024 (USD Million)
Table 27 North America: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 28 North America: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 29 North America: Microtomes Market, By End User, 2017–2024 (USD Million)
Table 30 Conferences/Meetings/Courses/Workshops Held/To Be Held in the Us
Table 31 US: Key Macroindicators
Table 32 US: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 33 US: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 34 US: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 35 US: Microtomes Market, By End User, 2017–2024 (USD Million)
Table 36 Canada: Key Macroindicators
Table 37 Canada: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 38 Canada: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 39 Canada: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 40 Canada: Microtomes Market, By End User, 2017–2024 (USD Million)
Table 41 Europe: Microtomes Market, By Country, 2017–2024 (USD Million)
Table 42 Europe: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 43 Europe: Microtome Instruments Market, By Type, 2017–2024 (USD Million)
Table 44 Europe: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 45 Europe: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 46 Europe: Microtomes Market, By End User, 2017–2024 (USD Million)
Table 47 Germany: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 48 Germany: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 49 Germany: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 50 Germany: Microtomes Market, By End User, 2017–2024 (USD Million)
Table 51 UK: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 52 UK: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 53 UK: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 54 UK: Microtomes Market, By End User, 2017–2024 (USD Million)
Table 55 France: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 56 France: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 57 France: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 58 France: Microtomes Market, By End User, 2017–2024 (USD Million)
Table 59 Italy: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 60 Italy: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 61 Italy: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 62 Italy: Microtomes Market, By End User, 2017–2024 (USD Million)
Table 63 Spain: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 64 Spain: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 65 Spain: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 66 Spain: Microtomes Market, By End User, 2017–2024 (USD Million)
Table 67 RoE: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 68 RoE: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 69 RoE: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 70 RoE: Microtomes Market, By End User, 2017–2024 (USD Million)
Table 71 Asia Pacific: Microtomes Market, By Country, 2017–2024 (USD Million)
Table 72 Asia Pacific: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 73 Asia Pacific: Microtome Instruments Market, By Type, 2017–2024 (USD Million)
Table 74 Asia Pacific: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 75 Asia Pacific: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 76 Asia Pacific: Microtomes Market, By End User, 2017–2024 (USD Million)
Table 77 Japan: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 78 Japan: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 79 Japan: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 80 Japan: Microtomes Market, By End User, 2017–2024 (USD Million)
Table 81 China: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 82 China: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 83 China: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 84 China: Microtomes Market, By End User, 2017–2024 (USD Million)
Table 85 India: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 86 India: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 87 India: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 88 India: Microtomes Market, By End User, 2017–2024 (USD Million)
Table 89 RoAPAC: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 90 RoAPAC: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 91 RoAPAC: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 92 RoAPAC: Microtomes Market, By End User, 2017–2024 (USD Million)
Table 93 RoW: Microtomes Market, By Product, 2017–2024 (USD Million)
Table 94 RoW: Microtome Instruments Market, By Type, 2017–2024 (USD Million)
Table 95 RoW: Microtomes Market, By Application, 2017–2024 (USD Million)
Table 96 RoW: Microtomes Market, By Technology, 2017–2024 (USD Million)
Table 97 RoW: Microtomes Market, By End User, 2017–2024 (USD Million)

List of Figures (35 Figures)
Figure 1 Microtomes Market Segments
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation: Bottom-Up Approach
Figure 5 Market Size Estimation: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Microtomes Market, By Product, 2019 vs. 2024 (USD Million)
Figure 8 Microtome Instruments Market, By Type, 2019 vs. 2024 (USD Million)
Figure 9 Microtomes Market, By Application, 2019 vs. 2024 (USD Million)
Figure 10 Microtomes Market, By Technology (USD Million)
Figure 11 Microtomes Market, By End User, 2019 vs. 2024 (USD Million)
Figure 12 Geographical Snapshot: Microtomes Market
Figure 13 Microtomes Market to Witness Single-Digit Growth Rate During the Forecast Period
Figure 14 Hospital Laboratories to Command the Largest Share of the Apac Microtomes Market in 2019
Figure 15 Semi-Automated Microtomes to Register the Highest Growth Rate During the Forecast Period
Figure 16 Disease Diagnosis Segment is Projected to Dominate the Microtomes Market in 2024
Figure 17 Microtome Instruments Segment to Witness the Highest Growth During the Forecast Period
Figure 18 China to Register the Highest Cagr During the Forecast Period
Figure 19 Microtomes Market: Drivers, Restraints, and Opportunities
Figure 20 Microtome Accessories to Register the Highest Growth During the Forecast Period
Figure 21 Disease Diagnosis Segment Will Continue to Dominate the Microtomes Market During the Forecast Period
Figure 22 Manual Microtomes Segment Will Continue to Dominate the Microtomes Market in 2024
Figure 23 Hospital Laboratories Segment to Dominate the Microtomes Market During the Forecast Period
Figure 24 North America: Microtomes Market Snapshot
Figure 25 US: Cancer Statistics
Figure 26 Canada: Cancer Statistics
Figure 27 Europe: Microtomes Market Snapshot
Figure 28 Asia Pacific: Microtomes Market Snapshot
Figure 29 RoW: Microtomes Market Snapshot
Figure 30 Key Developments in the Microtomes Market Between 2016 and 2019
Figure 31 Market Evolution Framework
Figure 32 Microtomes Market Share Analysis, By Key Player, 2018
Figure 33 Microtomes Market (Global) Competitive Leadership Mapping, 2019
Figure 34 Company Snapshot: Danaher
Figure 35 Company Snapshot: Thermo Fisher Scientific

★調査レポート[ミクロトームの世界市場予測（～2024年）] ( Microtome Market by Product (Instruments, (Rotary, Cryostat), Accessories), Application (Disease Diagnosis, Medical Research), Technology (Manual, Semi-automated, Fully Automated), End User (Hospital, Clinical Laboratories) - Global Forecast to 2024 / MD 7308) 販売に関する免責事項

[ミクロトームの世界市場予測（～2024年）] ( Microtome Market by Product (Instruments, (Rotary, Cryostat), Accessories), Application (Disease Diagnosis, Medical Research), Technology (Manual, Semi-automated, Fully Automated), End User (Hospital, Clinical Laboratories) - Global Forecast to 2024 / MD 7308) についてEメールでお問い合わせ

◆関連調査資料◆

エキソソーム研究関連製品の世界市場予測（～2024年）
BT 6939 / MarketsandMarkets / 2019年2月28日 / エキソソーム研究関連製品の世界市場は、2019年の9,100万米ドルから2024年には2億6,400万米ドルに達し、この期間中23.8％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、ライフサイエンス研究への資金提供の増加、がんの蔓延、およびエキソソームベースの治療への関心の高まりなどが考えられます。一方で、熟練した専門家の不足により、この市場の成長は抑制される可能性があります。当調査レポートでは、エキソソーム研究関連製品の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品・サービス（キット、試薬、機器、サービス）分析、用途（がん）分析、エンドユーザー（病院、学術機関、研究所）分析、エキソソーム研究関連製品の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“High global prevalence of cancer and increasing funding for life sciences are expected to drive the overall growth of the exosome research products market”The global exosome research products market is projected to reach USD 264 million by 2024 from USD 91 million in 2019, at a CAGR of 23.8% during the forecast period. Factors driving the growth of this market include the increasing funding for life science research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. However, the dearth of skilled professionals is a major factor that is expected to restrain the growth of this...

尿検査の世界市場予測（～2024年）
MD-3259 / MarketsandMarkets / 2019年3月29日 / 尿検査の世界市場は、2019年の32億米ドルから2024年には46億米ドルに達し、この期間中7.6％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、腎疾患や尿路感染症の世界的な蔓延、沈査分析の自動化への移行、ポイントオブケア尿検査の採用の増加などが考えられます。尿検査および新興国向けの統合システムは、市場プレイヤーに幅広い成長機会を提供すると期待されています。当調査レポートでは、尿検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別（ディップスティック、妊娠検査キット、試薬、消耗品、自動・半自動分析装置、PoC検査装置）分析、用途別（UTI、糖尿病、妊娠）分析、エンドユーザー別（病院、検査室、在宅医療）分析、検査の種類別分析、尿検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Urinalysis market to register a CAGR of 7.6% from 2019 to 2024”The global urinalysis market is projected to reach USD 4.6 billion by 2024 from USD 3.2 billion in 2019, at a CAGR of 7.6% from 2019 to 2024. The growth of the market is largely driven by factors such as the growing global prevalence of kidney diseases and urinary tract infections, the shift towards automation in sediment analysis, and the increasing adoption of point-of-care urinalysis. Integrated systems for urinalysis and the emerging economies are expected to provide a wide range of growth opportunities for players in the market. “Consumables...

吸引＆生検針の世界市場予測（～2024年）：細針吸引、生検（コア＆バキュームアシスト）
MD 7195 / MarketsandMarkets / 2019年7月1日 / 当調査レポートでは、吸引＆生検針の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別（細針吸引、生検（コア＆バキュームアシスト））分析、サイト別分析、処置別（画像誘導（超音波、MRI、定位）、非画像誘導）分析、エンドユーザー別（病院、学界）分析、吸引＆生検針の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The aspiration and biopsy needles market is projected to grow at a CAGR of 7.3%.”The aspiration and biopsy needles market is projected to reach USD 1,272 million by 2024 from USD 894 million in 2019, at a CAGR of 7.3%. The adoption of aspiration and biopsy needles is growing across major healthcare markets owing to the increasing incidence of cancer and the rising patient preference for minimally invasive diagnostic procedures. “The Biopsy Needles segment is expected to witness the highest growth in the aspiration and biopsy needles market during the forecast period.” On the basis of product, the aspiration and...

血液腫瘍検査の世界市場予測（～2024年）：アッセイキット、サービス
MD 7180 / MarketsandMarkets / 2019年6月28日 / 当調査レポートでは、血液腫瘍検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品・サービス別（アッセイキット、サービス）分析、がん別（白血病（急性リンパ芽球性、急性骨髄性）、非ホジキンリンパ腫）分析、技術別（PCR、NGS、IHC）分析、エンドユーザー別（臨床検査室、病院）分析、血液腫瘍検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Hemato oncology testing market to register a CAGR of 14.8% from 2019 to 2024”The hemato oncology testing market is projected to reach USD 4.0 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 14.8% during the forecast period. Growth in this market is mainly driven by the rising incidences & prevalence of leukemia, increasing collaborations for developing new assay kits, and the growing focus on personalized medicine. “Services accounted for the larger share of the hemato oncology testing market in 2018” Based on product & service, the market is segmented into assay kits and services. In...

吸引＆生検針の世界市場予測（～2024年）
MD-7195 / MarketsandMarkets / 2019年7月25日 / 当調査レポートでは、吸引＆生検針の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別（細針吸引、生検（コア・真空アシスト））分析、部位別分析、処置別（画像ガイド（超音波、MRI、定位）、非画像ガイド）分析、エンドユーザー別（病院、学界）分析、吸引＆生検針の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。MarketsandMarkets社は、吸引＆生検針の世界市場規模が2019年894百万ドルから2024年1272百万ドルまで年平均7.3％成長すると予測しています。...“The aspiration and biopsy needles market is projected to grow at a CAGR of 7.3%.” The aspiration and biopsy needles market is projected to reach USD 1,272 million by 2024 from USD 894 million in 2019, at a CAGR of 7.3%. The adoption of aspiration and biopsy needles is growing across major healthcare markets owing to the increasing incidence of cancer and the rising patient preference for minimally invasive diagnostic procedures. “The Biopsy Needles segment is expected to witness the highest growth in the aspiration and biopsy needles market during the forecast period.” On the basis of product, the aspiration...

細胞増殖の世界市場予測（～2024年）
BT-2850 / MarketsandMarkets / 2019年4月1日 / 当調査レポートでは、細胞増殖の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別（試薬、培地、フローサイトメトリー、遠心分離機、バイオリアクター）分析、細胞種類別（ヒト、動物）分析、用途別（再生医療・幹細胞研究、癌・細胞ベース研究）分析、エンドユーザー別（病院、医薬品、バイオテクノロジー）分析、細胞増殖の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Cell expansion market to register a CAGR of 15.4% from 2019 to 2024” The cell expansion market is projected to reach USD 26.0 Billion by 2024 from USD 12.7 Billion in 2019, at a CAGR of 15.4% during the forecast period. Growth in this market is mainly driven by the increasing incidence of chronic diseases, government investments for cell-based research, the growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities. “Consumables accounted for the larger share of the cell expansion market in 2018” On the basis of products,...

気道ステント・肺ステントの世界市場予測（～2024年）
MD 5762 / MarketsandMarkets / 2019年6月20日 / 当調査レポートでは、気道ステント・肺ステントの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類（気管、気管支、喉頭ステント）別分析、製品（非拡張型、自己拡張型ステント）別分析、材料（金属（ニチノール、ステンレス鋼）、シリコン、ハイブリッド）別分析、エンドユーザー (病院、ASC）別分析、気道ステント・肺ステントの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The airway stent/lung stent market is projected to reach USD 120 million by 2024 from USD 87 million in 2019, at a CAGR of 6.7%. The. Factors such as rise in prevalence of lung cancer, increasing incidence of chronic respiratory diseases, continuous growth in the healthcare industry, and rising preference towards minimally invasive procedures are expected to drive the growth of the airway stent/lung stent market. However, the complications associated with stents and the availability of alternative treatments are anticipated to impede the growth of this market to a certain extent. The tracheobronchial stents segment is projected to witness the...

がん患者登録ソフトウェアの世界市場予測（～2024年）
HIT-6993 / MarketsandMarkets / 2019年3月28日 / がん患者登録ソフトウェアの世界市場は、2019年の5,500万米ドルから2024年には9,100万米ドルに達し、この期間中10.4％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、がんの罹患率の増加、政府による積極的な取り組み、EHRの採用の増加、市販直後調査を目的としたがん患者登録データの利用増加、医療の質の向上、医療費削減に対する意識の高まりなどが考えられます。一方で、プライバシーとデータセキュリティ関連の懸念により、市場の成長は抑制される可能性があります。当調査レポートでは、がん患者登録ソフトウェアの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、タイプ（スタンドアロン型、統合型）分析、導入モード（オンプレミス、クラウド）分析、データベース（民間、公共）分析、機能性（がん報告、患者ケア、医学研究）分析、がん患者登録ソフトウェアの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Cancer patient registry software market projected to grow at a CAGR of 10.4%” The cancer patient registry software market is projected to reach USD 91 million by 2024 from USD 55 million in 2019, at a CAGR of 10.4%. Factors such as the growing prevalence of cancer, favorable government initiatives, rising adoption of EHRs, growing use of cancer patient registry data for post-marketing surveillance, and rising pressure to improve the quality of care and reduce healthcare costs are driving the growth of this market. However, privacy and data security-related concerns may restrain the growth of this market to a certain...

血液腫瘍検査の世界市場予測（～2024年）
MD-7180 / MarketsandMarkets / 2019年6月24日 / 当調査レポートでは、血液腫瘍検査の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品＆サービス別（アッセイキット、サービス）分析、がん別（白血病（急性リンパ芽球性、急性骨髄性）、非ホジキンリンパ腫）分析、技術別（PCR、NGS、IHC）分析、エンドユーザー別（臨床研究所、病院）分析、血液腫瘍検査の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。MarketsandMarkets社は、血液腫瘍検査のの世界市場規模が2019年20億ドルから2024年40億ドルまで年平均14.8％成長すると予測しています。...“Hemato oncology testing market to register a CAGR of 14.8% from 2019 to 2024” The hemato oncology testing market is projected to reach USD 4.0 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 14.8% during the forecast period. Growth in this market is mainly driven by the rising incidences & prevalence of leukemia, increasing collaborations for developing new assay kits, and the growing focus on personalized medicine. “Services accounted for the larger share of the hemato oncology testing market in 2018” Based on product & service, the market is segmented into assay kits and services....

術中放射線療法（IORT）の世界市場予測（～2024年）
MD 7339 / MarketsandMarkets / 2019年9月10日 / 当調査レポートでは、術中放射線療法（IORT）の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、方法別（電子IORT、術中近接照射療法）分析、製品及びサービス別（加速器、治療計画システム、アプリケーター、アフターローダー、アクセサリー）分析、用途別（乳房、脳）分析、術中放射線療法（IORT）の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。MarketsandMarkets社は、術中放射線療法（IORT）の世界市場規模が2019年48百万ドルから2024年68百万ドルまで年平均7.0%成長すると予測しています。...“The intraoperative radiation therapy market is projected to grow at a CAGR of 7.0% during the forecast period.”The global intraoperative radiation therapy market is projected to reach USD 68 million by 2024 from USD 48 million in 2019, at a CAGR of 7.0%. The rising incidence of cancer, technological advancements, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players. However, the complex nature of...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆